SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is experiencing extreme volatility and a sharp sell-off, prompting intense community debate over whether it's market manipulation and dilution or a strategic shakeout, despite surging crude oil prices and rallies in other energy stocks amidst escalating Middle East tensions. Many anticipate a massive rebound due to its low float and high short interest, drawing parallels to its past explosive moves, while awaiting updates on its upcoming drilling activities.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is generating significant buzz following its earnings, which featured a double beat on expectations and robust ARR growth, alongside an optimistic FY27 outlook that has spurred analyst upgrades. The community is actively debating its premium valuation and whether AI represents a new tailwind for increased cybersecurity demand, especially given broader geopolitical concerns, though some remain skeptical about its current price multiples.

Texxon Holding Ltd. provides supply chain management services in East China. Its services include the sale of plastic, chemical raw materials, and other plastic raw materials. Its products are used in fabrics, coastings, resins, beverage packing, other downstream products, pipelines and pipes used in infrastructure, daily or food grade packing and agriculture membranes. The company was founded on January 20, 2022 and is headquartered in Shanghai, China.

Texxon Holding Ltd

Texxon Holding Ltd (NPT) is experiencing a massive breakout day with extremely high volume, driving significant price volatility and numerous trading halts. The community is keenly focused on its low float and "Chinese stock" nature, fueling both ambitious price targets and cautionary tales of potential rapid reversals amidst active trading.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab (GTLB) is trending after its earnings report showed beats on current quarter revenue and EPS but softer-than-expected future revenue guidance, coupled with a $400 million share repurchase authorization. The community is fiercely debating the slowing growth and path to profitability versus the impact of the buyback and potential benefits from AI integration, all within a broader market sentiment of AI vulnerability for software companies.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following a business update that showcased significant revenue growth and global expansion of its cancer therapies into new markets like Saudi Arabia and Europe. The community is split between excitement for the CEO's ambitious vision of curing cancer and long-term potential, and frustration over the perceived lack of immediate financial catalysts, fueling ongoing debates about market manipulation.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is experiencing intense volatility as escalating Middle East tensions, marked by reported strikes and concerns over oil flow, fuel a sharp divide among traders. While some anticipate further market declines, many are actively discussing strategies to capitalize on the notable post-market drops and open-session rebounds, with recent announcements about US naval escorts and insurance for tankers adding to the complex sentiment.

SSgA Active Trust - State Street SPDR Dow Jones Industrial Average ETF Trust

DIA is trending as escalating US-Israel-Iran tensions drive market volatility, with community sentiment split between investors buying the dip, citing historical resilience, and those anticipating broader market instability due to surging oil prices and inflation concerns.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is highly volatile amid escalating Middle East tensions and the US response to secure shipping lanes, driving sharp "V-shaped" recoveries that reward dip buyers. The community remains deeply polarized, with many expressing frustration over perceived market manipulation while others anticipate further declines given the ongoing geopolitical uncertainty.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as the community eagerly awaits imminent Phase 3 results for its AML treatment, GPS, with many interpreting extended patient survival as a strong indicator of success. This is fueling speculation of a multi-billion dollar buyout and pushing the stock to new highs in an otherwise down market.

Gran Tierra Energy, Inc engages in the exploration and production of oil and natural gas in Colombia and Ecuador. It holds interests in the assets located in the Middle Magdalena Valley and Putumayo Basins. The company was founded on June 6, 2003 and is headquartered in Calgary, Canada.

Gran Tierra Energy Inc

Gran Tierra Energy is trending as its latest earnings and a strategic acquisition diversifying into Canadian assets spark debate among investors, who are closely watching management's debt strategy amid elevated oil prices and geopolitical volatility impacting the energy sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. In Europe, Rubraca is approved for use in recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.

CLVSQ
Clovis Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CLVSQ News

CLVSQClovis Oncology Inc